Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) shares rose on Thursday December 29 with heavier trade volume than normal after a number of analysts weighed in on the investing value of the stock with a downgraded rating.
Meanwhile, U.S. stocks were little changed in early trade Thursday. The S&P 500 SPX, +0.04% rose 0.1% to 2,252, while the Dow DJIA, +0.04% advanced 16 points to 19,850. The Nasdaq Composite COMP, -0.04% was virtually flat at 5,439.
Shares of Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) were downgraded by analysts at Citigroup Inc. in a note to their investors today. With a rating of Neutral on the shares, Anthera Pharmaceuticals Inc. has a 52-week high of $4.90. The one-year price target of $4.67 is above the opening price of $0.76, resulting a fair amount of other analysts to comment on the stock in recent days. Material and crucial changes in the company’s operations, future direction or industry can cause downgrades as the analysts believe that the future prospects for the security have diminished from the initial recommendation.
Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) shares last traded at $0.78, which represents a spike of $0.04 or 5.69% compared to the previous closing price. Opening at $0.76, they fluctuated from $0.76 and $0.84 throughout the day.
Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) now has a market cap of 32.90M.
Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) Average Daily Trading Volume
The stock’s average daily volume is 1,482,040 shares out of a total float 36,811,000 and some 3,012,487 shares crossed the trading desk yesterday, higher than normal. Considerable volume accumulation by institutional investors may be on the horizon as the combination of large expansions in trading volume and price appreciation can be deciding factors.
However, just a day of significant buy side trading is not enough to affirm a trend. So market traders will continue to look for institutional sponsorship as a cue that financial institutions are moving forward.
Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.
These instituitional investors retain teams of analysts that research thousands of stocks. So watching their interests is a good way to make sure you are buying the right stocks.
Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) Moving Averages
A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.
This is because the average acts like a floor (support), so the price bounces up off of it.
In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.
By following the activity of these professional investors—and the moving averages they affect— traders are able to make make smarter trades.
With that in mind, Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) now has a 50-day MA of $1.82 and 200-day MA of $2.74. It has traded in a 52-week range between $0.67 – 4.9000 and today’s last price is 84.00%% lower than the 52 week high of $4.90.
Earnings growth is an important factor to research when buying stocks and investors seek companies that have increased their earnings by at least 25% over the past 3 years.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.